Open AccessmRNA vaccines: Why and how they should be modified
Author(s) -
Isidoro Feliciello,
Alfredo Procino
Publication year - 2021
Publication title -
journal of biological research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 6
eISSN - 2284-0230
pISSN - 1826-8838
DOI - 10.4081/jbr.2021.10072
Subject(s) - messenger rna , virology , covid-19 , pandemic , coronavirus , biology , severe acute respiratory syndrome coronavirus , rna , computational biology , medicine , genetics , gene , outbreak , infectious disease (medical specialty) , pathology , disease
The COVID-19 pandemic has stimulated the production of different therapeutic approaches for the resolution of coronavirus infections. On one hand, nanobiomolecules have been proposed as bait material for viruses,1,2 on the other hand unconventional messenger RNA vaccines have been produced like SARS-CoV-2 mRNA vaccines (BioNTech/Pfizer BNT162b2 and Moderna mRNA-1273). [...]